Researchers from the UK and Australia found that a brain-aging biomarker based on neuroimaging data showed that brains that appeared older were linked to increased mortality risk, poorer lung function, slower walking speed, reduced grip strength, lower fluid intelligence and higher allostatic load, and mortality risk prediction was improved by combining the biomarker and DNA-methylation-predicted age. The findings in Molecular Psychiatry suggest the biomarker could be useful in identifying asymptomatic people with adverse aging, researchers said.
An American Society of Clinical Oncology clinical guideline governing treatment of patients with metastatic pancreatic cancer includes strong recommendations that patients be informed about palliative care. The guideline, published in Journal of Oncology Practice following a review of scientific evidence, said patients will need assessments of symptom burden and, in most cases, those assessments will "indicate a need for formal palliative care consult and services."
A study published in The BMJ found riding a bike to work, compared with a sedentary commute, was associated with a 46% reduced risk of cardiovascular disease, a 45% lower likelihood of cancer and a 41% lower chance of premature death over five years. Researchers said walking to work was linked to a 27% lower risk of CVD and a 36% lower likelihood of dying from it.
Pooled results from two late-stage trials of Adamas Pharmaceuticals' ADS-5102, or amantadine, showed that the drug produced a statistically significant reduction in "off time" and a significant reduction in dyskinesia associated with levodopa in patients with Parkinson's disease.
People who are active participants in their health care decisions, regardless of how bad their diagnosis, have the best chance of receiving care consistent with their values, goals and preferences, said palliative care specialist Dr. Steven Pantilat of the University of California at San Francisco School of Medicine. Pantilat, author of "Life After the Diagnosis," said patients should ask their physicians lots of questions and push for a prognosis.
Four online advisory letters and 14 warning letters were issued by the FDA to US-based firms for marketing and selling more than 65 products with claims that they could cure, prevent or reverse cancer, although the claims are not proven and the products have not gotten the approval of the FDA. The agency gave the companies 15 days to respond with plans on how they will address their violations, and companies that do not comply face product seizure and criminal prosecution that could result in a year in federal prison and a fine of either $100,000 or twice the company's gain on the fraudulent products.
The CMS will accept formal comments on proposed changes to the Medicare and Medicaid EHR Incentive Programs until June 13. These changes include revising the EHR reporting period from the full calendar year to any continuous 90-day period, implementing a policy that would not allow payment adjustments for eligible providers who conduct most of their professional services in ambulatory surgery centers, and adding a Medicare payment adjustment for eligible hospitals and professionals who cannot comply with meaningful-use requirements because of decertified technology.
SERMO surveyed 3,086 physicians from 26 countries and found that 46% have witnessed an EMR/EHR outage or malfunction that endangered a patient's health or safety. Fifty-five percent of physicians in the US said they experienced such an incident, followed by 46% -- the global average -- in Canada and the UK and 39% in France.
Save 10% on the Steves' Review of Nuclear Medicine Technology, 4th edition, and Practical Mathematics in Nuclear Medicine Technology, 2nd edition, when you purchase them together as part of the best-selling Technologist Study Combo. It's an in-depth review at a great price!
The empires of the future are the empires of the mind.
Winston Churchill, statesman and prime minister
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items above are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at firstname.lastname@example.org.